Juliana Hagembe

Juliana Hagembe is a skilled public health professional and health system strengthening specialist based in Kenya. Holding both a master’s degree in public health and biochemistry, she is dedicated to increasing access to diagnosis and treatment in low-resource settings. As an Outreach and Diagnostic Consultant for WFH, Juliana leverages over 10 years of experience in conceiving and implementing innovative, evidence-based solutions for underserved communities in limited-resource settings. Her expertise in public health and biochemistry enables her to drive improvements in healthcare services.

Donna Coffin

Donna Coffin, MSc is currently the Director, Research & Education at the World Federation of Hemophilia (WFH) in Montreal, Canada. Donna is an epidemiologist, trained at McGill University in Montreal, and has spent much of her career conducting evidence based research for health care and regulatory agencies around the world. Since joining the WFH in 2016, Donna has established the Research & Education department, with focus on the development and implementation of the World Bleeding Disorders Registry. Her team is also responsible for all WFH research activities, including the WFH Annual Global Survey, the WFH Clinical Research Grant Program, and the production of evidence-based advocacy tools used to promote treatment for all.

Erich Vinicius de Paula

Erich De Paula is an Associate Professor of Hematology at University of Campinas, in Campinas, SP, Brazil. His main interest in teaching, research and medical care are diseases involving thrombosis and hemostasis. He currently holds the position of medical consultant of the national program for hereditary bleeding disorders of the Ministry of Health in Brazil.

Flerida Hernandez

Physician Hemophilia Philippines (HAPLOS Community) Foundation, Inc. Manila, Philippines

Premroop Alva

Born with severe hemophilia B, Prem has been involved in Haemophilia movement in Karnataka and India for over 25 years. He has held various positions in his chapter and the national NMO. He was one of the architects of evidence-based advocacy initiatives in India and played a huge role in establishing the National Hemophilia Registry of Hemophilia Federation (India). Prem has been actively involved in advocating for improvement of treatment and diagnostic facilities in several states of India and led various development projects in HFI. He contributions have led to establishment of several comprehensive hemophilia care centres in the country. Prem is also a member of State Blood Cell, a government decision-making body on blood & bleeding disorders in the state of Karnataka, India.

Tahani Ali

Dr. Tahani ALI, Professor, M.D.: Hematology & blood transfusion, Faculty of medicine, Damascus University

Mark Skinner

Mark Skinner, Washington, DC, is President/CEO of the Institute for Policy Advancement Ltd, specializing in patient-centered outcomes research. He is an Assistant Professor in the Department of Health Research Methods, Evidence and Impact at McMaster. He has previously led both national and international patient organizations including the World Federation of Hemophilia and National Hemophilia Foundation where he currently serves on their Medical and Scientific Advisory Council. He is the principal investigator for the Patient Reported Outcomes Burdens and Experiences (PROBE) study, a global research project to enhance the direct patient voice in healthcare decision-making. He holds numerous roles as an advisor on critical blood safety and supply matters including having served on the US Health and Human Services Advisory Committee on Blood and Tissue Safety and Availability. He serves on the board of the Institute for Clinical and Economic Review (ICER), the National Organization for Rare Disorders (NORD) and formerly the Patient Centered Outcomes Research Institute (PCORI) Advisory Panel on Rare Disease, where he was an inaugural member. Previously, he was Vice President State Programs at the American Insurance Association and Administrative Assistant/Chief of Staff to the Speaker of the Kansas House of Representatives. He holds degrees in Public and Business Administration from Kansas State University and JD from Washburn University School of Law.

Glenn Pierce

Dr. Glenn Pierce currently serves on the WFH as VP Medical and WFH USA Board of Directors and NHF (US) Medical and Scientific Advisory Council. He is an Entrepreneur-in-residence at Third Rock Ventures, and a biotech consultant in the gene therapy and hematological areas.

Courtney Thornburg

Dr. Courtney Thornburg is the Director of the Hemophilia and Thrombosis Treatment Center at Rady Children’s Hospital San Diego and Professor of Pediatrics at the University of California-San Diego. Dr. Thornburg graduated from Duke University Medical School, completed her pediatric residency at Duke University Medical Center, and completed her pediatric hematology/oncology fellowship at the University of Michigan. While at the University of Michigan, she completed a Master Degree in Clinical Research Design and Statistical Analysis. During her time in Michigan she focused her training on hemophilia and other bleeding disorders and was a NHF-Shire Clinical Fellow under the mentorship of Dr. Steven Pipe. Dr. Thornburg was on the faculty at Duke University from 2005-2013 where she directed the sickle cell and hemostasis and thrombosis programs. Dr. Thornburg is committed to taking care of children with blood disorders including bleeding disorders, clotting disorders and inherited red blood cell disorders. She conducts clinical research to improve the care of individuals with blood disorders. She received an NHF Innovative Investigator Research Award and an investigator initiated award from Biomarin to study patient preferences and shared-decision making related to gene therapy for hemophilia. She is part of the WFH working group on shared decision-making. In order to educate the next generation of physicians, Dr. Thornburg teaches medical students, residents and fellows and is the Director of the Pediatric Hemostasis and Thrombosis Fellowship at RCHSD, a site for the NHF-Takeda Clinical Fellowship program. Dr. Thornburg is a member of NHF’s Medical and Scientific Advisory Council (MASAC). In addition to her career in medicine, Dr. Thornburg enjoys spending time with her family, traveling and playing tennis.

Cedric Hermans

Cedric Hermans currently heads the Division of Haematology, the Hemostasis and Thrombosis Unit as well as the Hemophilia Center of the Saint-Luc University Hospital in Brussels, Belgium. He was appointed Associate Professor at the Medical School of the Catholic University of Louvain in 2003, Full Professor in 2012 and Vice-Dean in 2015. Professor Hermans has (co)-authored more than 320 original articles in international journals and is a member of several scientific societies and international advisory boards and collaborative research projects. He is Member of the Royal Academy of Medicine of Belgium and Fellow of the Royal Colleges of Physicians of London and Edinburgh.He was president of EAHAD and is currently member of the Board of Directors of the World Federation of Haemophilia and the Editor-in-Chief of the Haemophilia Journal. His main research interests lie in the area of haemostasis and thrombosis, especially clinical studies on the treatment modalities and the wide spectrum of complications of haemophilia in both developed and developing countries, as well as new anticoagulants and the management of thrombosis.